Home > Insider Trading > Filing (0000950170-24-040302)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1556263	Syros Pharmaceuticals Inc.	SYRS	Pharmaceutical Preparations (2834)	453772460

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1599014	David Roth	C/O Syros Pharmaceuticals, Inc. 35 Cambridgepark Drive Cambridge MA 02140	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-03-31	2,000	$0.00	2,000	No	4	M	Direct
Common Stock	Acquisiton	2024-03-31	13,333	$0.00	15,333	No	4	M	Direct
Common Stock	Disposition	2024-04-01	4,732	$5.12	10,601	No	4	F	Direct
Common Stock	Disposition	2024-04-02	150	$4.98	10,451	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2024-03-31	2,000	$0.00	2,000	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-03-31	13,333	$0.00	13,333	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,000			No	4	M	Direct
26,667			No	4	M	Direct

Footnotes

Represents shares of common stock received upon vesting of a restricted stock unit award.
Represents shares used to cover tax withholding upon the release of restricted stock units.
The sale was effected pursuant to a trading plan adopted on March 27, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.97 to $5.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Represents a restricted stock unit award granted on February 15, 2022. These restricted stock units vest in four equal annual installments commencing on March 31, 2023.
Represents a restricted stock unit award granted on February 16, 2023. These restricted stock units vest in three equal annual installments commencing on March 31, 2024.